Overview
Chia-hui Lin practices practicing medicine in Taiwan.
Their clinical expertise encompasses Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chia-hui Lin
Is Chia-hui Lin a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Chia-hui Lin is classified as an Experienced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chia-hui Lin participate in research or clinical trials?
Yes. Chia-hui Lin has published 16 articles and abstracts on conditions like Long Haul COVID. You can view a list of Chia-hui Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Long Haul COVIDLin isExperienced. Learn about Long Haul COVID.
- Maturity Onset Diabetes of the Young
- Severe Acute Respiratory Syndrome (SARS)
- Type 2 Diabetes (T2D)Lin isExperienced. Learn about Type 2 Diabetes (T2D).